Haryana, 31 January 2025: ZELIO E Mobility, a leading player in India’s electric two-wheeler market, has announced a strategic partnership with Ecofy, India’s first green-focused Non-Banking Financial Company (NBFC). This tie-up aims to make electric vehicles (EVs) more accessible and affordable for customers across the country, enabling them to purchase ZELIO’s popular models, including the X-Men, Gracy, Eeva, and Mystery. The partnership comes shortly after ZELIO’s association with LoanTap, a leading online personal loan platform, further enhancing their financing options for customers.

The Ecofy financing scheme offers a host of benefits for ZELIO E Mobility’s dealers, providing them with tools to boost sales and engage with customers effectively. Customers can enjoy low-interest rates, a quick approval process, and customizable EMI options, making EV purchases more accessible. The entirely digital and paperless financing process allows for a smooth, hassle-free loan application, setting it apart from traditional methods. Additionally, the accessibility of the Loan & EMI Monitoring App ensures customers stay informed and in control of their repayment schedules.

Mr. Kunal Arya, Co-Founder and Managing Director of ZELIO E Mobility Ltd., stated, “As the demand for electric two-wheelers rises, many customers are seeking affordable financing options to manage the upfront cost of these vehicles. Our partnership with Ecofy directly addresses this need by offering flexible and competitive financing plans, making electric two-wheelers more accessible. This collaboration reinforces our commitment to promoting sustainable mobility and providing customers with a seamless path to adopting eco-friendly transportation solutions.”

ZELIO E Mobility is committed to ensuring that its dealers have the resources they need to successfully promote and explain ECOFY’s financing options. Dealers will undergo specialized training programs to fully understand the financing products and assist customers in navigating the application process. Digital tools such as QR codes will simplify loan access, and dedicated field support will be available to address any questions. Marketing materials, including brochures and posters, will help dealers communicate the financial and environmental benefits of eco-friendly purchases effectively.

To further incentivize customers, special promotions and limited-time offers will be available under the ECOFY financing scheme. These promotions include lower interest rates, extended loan tenures, and waived processing fees, all designed to encourage more people to make the shift to electric two-wheelers. ZELIO E Mobility also plans to monitor the success of its partnership with Ecofy through several key performance indicators, including sales metrics, customer satisfaction, and dealership performance.

Since its inception, ZELIO E Mobility has established itself as a frontrunner in the electric two-wheeler market. With a customer base of over 200,000 riders and more than 273 dealerships, ZELIO is rapidly growing its presence across India. The EV two-wheeler brand is focused on expanding its market share and reaching more customers, with plans to increase its dealership network to 400 locations by March 2025.

Mumbai, India – January 31, 2025 – IceWarp has been recognized with the CIO CHOICE 2025 Honor and Recognition as the most Trusted ICT Brand by CIOs and Digital Leaders in the Enterprise Email category.

Now in its 13th year, CIO CHOICE continues to be the most prestigious and only discovery recognition platform, honoring ICT brands for their excellence in product and service innovation, customer-centric approaches, and efficient delivery, selected based on the stated preferences of CIOs and ICT Decision Makers.

This distinguished recognition was bestowed at the exclusive CIO CHOICE 2025 Red Carpet Night, produced by CORE Media, with KPMG as the Knowledge Partner.

This year’s event brought together over 400 CIOs and Digital Leaders from across the country, making it a truly remarkable gathering of industry influencers.

CIO CHOICE is known as the ‘Seal of Trust,’ given to ICT brands by the very CIOs and Digital Leaders who rely on them.

The winning brands are selected through a unique pan-India voting platform, where CIOs and Digital Leaders nominate and vote for their most trusted and preferred brands, based on their firsthand experiences and top-of-mind recall. A distinguished Advisory Panel of seasoned CIOs from various industry sectors oversees and guides the entire process, ensuring its integrity and credibility.

This year’s advisory panel consisted of 10 distinguished CIOs and Digital Technology leaders:

• Aasish Kshetry, CIO & VP – IT, Asian Paints
• Dheeraj Sinha, EVP and Global CIO, Sun Pharma
• Jyothirlatha B, CTO, Godrej Capital
• Narendra Sonawane, SVP, Global Head, IS, Infosys
• Ramesh Narayanaswamy, CTO, Aditya Birla Capital
• Rohit Kilam, CTO, HDFC Life
• Rucha Nanavati, CIO, Mahindra Group
• Subhash Kelkar, CIO, BSE
• Vinod Sivrama Krishnan, CDIO, Essar Capital
• Vishal Bhatia, CDO, Canara Bank

Anoop Mathur, Founder of CORE Media said “Congratulations to IceWarp for earning the prestigious CIO CHOICE 2025 Trust Seal. This recognition is a true reflection of the brand‘s commitment to delivering exceptional experiences to enterprise customers. The trust bestowed upon IceWarp by India’s CIOs and Digital Leaders, amidst shifting consumer trends in a dynamic economy, is truly commendable. In a time where technology propels business advancement, the CIO Choice accolade solidifies IceWarp‘s position as an industry pioneer.”

The pharmaceutical (Pharma) and medical technology (MedTech) industries are evolving rapidly, driven by technological innovations, shifting regulatory landscapes, and changing patient needs. Here are some of the top trends to watch in 2025:

1. Artificial Intelligence (AI) and Machine Learning (ML) Integration

Drug Discovery & Development: AI and ML are accelerating drug discovery, identifying promising drug candidates faster and at lower costs by analyzing vast amounts of data to predict molecular behavior.

Personalized Medicine: AI tools help tailor treatments based on individual genetic profiles, improving efficacy and minimizing side effects.

Diagnostic Tools: AI-powered imaging and diagnostic systems are enhancing the accuracy and speed of disease detection, especially in fields like oncology and cardiology.

2. Sustainability and Green Practices

Eco-Friendly Packaging: Both Pharma and MedTech companies are focusing on reducing their environmental impact by transitioning to biodegradable, recyclable, and eco-friendly packaging for drugs and medical devices.

Sustainable Manufacturing: With growing attention on reducing carbon footprints, the focus is shifting toward green chemistry and sustainable manufacturing processes in drug and device production.

3. Regenerative Medicine & Cell Therapies

Stem Cell Research: Advances in stem cell therapies are opening new possibilities in the treatment of chronic diseases, injuries, and age-related conditions.

Gene Editing: Technologies like CRISPR are becoming more refined, offering potential for curing genetic disorders and personalizing treatments.

Tissue Engineering: The development of bioprinted tissues and organs, along with other regenerative techniques, may reduce organ shortages and provide alternatives to traditional organ transplants.

4. AI-Driven Healthcare Robotics

Surgical Robots: Robots are becoming more precise and minimally invasive in surgeries, leading to faster recovery times and fewer complications. Robotic surgeries and automated assistance tools are expected to see widespread adoption.

Robotic Caregiving: Robots designed to assist elderly or disabled individuals with daily tasks are gaining traction, improving quality of life and reducing caregiver burden.

5. Telemedicine & Remote Patient Monitoring

Post-Pandemic Growth: Telehealth remains a key trend, with many healthcare systems adopting it as a permanent feature. Remote consultations, monitoring, and follow-up care are streamlining healthcare delivery.

Wearables & IoT Devices: Wearables that track vital signs, glucose levels, heart rate, and other metrics will continue to grow, offering real-time data that can be used for early intervention.

Virtual Clinical Trials: The use of telemedicine and remote monitoring in clinical trials enables a wider pool of participants, reduces costs, and allows for quicker recruitment and data collection.

6. Advanced Diagnostics & Point-of-Care Testing

Non-Invasive Tests: Advancements in diagnostic tools, including liquid biopsies and home diagnostic kits, allow for non-invasive testing to detect diseases earlier, such as cancers, heart conditions, and infections.

Point-of-Care (POC) Devices: Devices that provide real-time diagnostic results at the point of care, such as in clinics, pharmacies, or even at home, are expected to become more advanced and accessible.

7. Digitization and Data Analytics in Pharma

Big Data in Pharma: Data analytics is becoming essential in understanding patient outcomes, streamlining drug development, optimizing manufacturing processes, and enhancing supply chain management.

Real-World Evidence: Real-world data is being used to better understand drug efficacy and patient outcomes beyond controlled clinical trials, leading to more informed regulatory decisions and treatment plans.

8. Mental Health and Digital Therapeutics

Mental Health Focus: There is growing recognition of mental health conditions, particularly in the context of the post-pandemic world. Digital therapeutic solutions, such as apps and online platforms for managing conditions like anxiety, depression, and PTSD, are gaining prominence.

Psychiatric Digital Health: Digital tools for therapy and medication management, along with advancements in neurostimulation devices and wearables, will shape mental health care in 2025 and beyond.

Mumbai, 31 January 2025: SILA, a leading player in facility management and real estate services, has teamed up with Schbang to launch a ground-breaking campaign that challenges societal perceptions of housekeepers. This initiative encourages audiences to reflect on their behaviours and biases, driving home the importance of treating housekeeping staff with the dignity and respect they deserve.

Despite the societal acknowledgment of housekeepers’ contributions, genuine respect often remains superficial. SILA and Schbang’s campaign seeks to disrupt this cycle by illuminating everyday hypocrisies and encouraging people to align their actions with their words.

The key component of this effort is a thought-provoking film ‘Sachh Hi Swachh Hai’ put together by Schbang. The narrative centers on a professional who, while fervently advocating for cleanliness workers in a work conference, unintentionally exposes his own prejudices at home. He is forced to consider his behaviour after having this epiphany, which results in the moving message:

“Swachh Banane Se Pehle Hume Sach Banna Hoga.”

The film emphasizes SILA’s continued commitment to transforming lives, as the company has already trained and employed over 27,000 Facility Management professionals in 125 cities across India.